Johns Hopkins HIV Guide
Zidovudine (AZT)
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretrovirals.
- Prevention of maternal-fetal transmission
- However, while an FDA indication, the labeled regimen is historical and current DHHS practice differs (see below).
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 6, 2026
Citation
Soto, Caitlin, and Christin Kilcrease. "Zidovudine (AZT)." Johns Hopkins HIV Guide Johns Hopkins HIV Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545223/all/Zidovudine__AZT_.
Soto C, Kilcrease C. Zidovudine (AZT). Johns Hopkins HIV Guide Johns Hopkins HIV Guide. The Johns Hopkins University; 2026. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545223/all/Zidovudine__AZT_. Accessed September 30, 2026.
Soto, C., & Kilcrease, C. (2026). Zidovudine (AZT). In Johns Hopkins HIV Guide Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545223/all/Zidovudine__AZT_
Soto C, Kilcrease C. Zidovudine (AZT) [Internet]. In: Johns Hopkins HIV Guide Johns Hopkins HIV Guide. The Johns Hopkins University; 2026. [cited 2026 September 30]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545223/all/Zidovudine__AZT_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Zidovudine (AZT)
ID - 545223
A1 - Soto,Caitlin,PharmD, BCIDP
AU - Kilcrease,Christin,Pharm.D.
Y1 - 2026/09/06/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545223/all/Zidovudine__AZT_
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
